Allogeneic stem cell transplantation for patients with acute myeloid leukemia (AML) in second complete remission (CR2) transplanted from unrelated donors with post-transplant cyclophosphamide (PTCy). A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Arnon Nagler*, Myriam Labopin, Ryszard Swoboda, Alexander Kulagin, Hélène Labussière-Wallet, Montserrat Rovira, Didier Blaise, Jan Vydra, Ibrahim Yakoub-Agha, Goda Choi, Péter Reményi, Yener Koc, Jaime Sanz, Fabio Ciceri, Mohamad Mohty
Research output: Contribution to journal › Article › peer-review
2Scopus
citations
Fingerprint
Dive into the research topics of 'Allogeneic stem cell transplantation for patients with acute myeloid leukemia (AML) in second complete remission (CR2) transplanted from unrelated donors with post-transplant cyclophosphamide (PTCy). A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation'. Together they form a unique fingerprint.